Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation

Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation

Objectives: Despite advances in screening and prevention, rates of premature coronary artery disease (CAD) have been stagnant. The goals of this study were to investigate the barriers to early risk detection and preventive treatment in patients with premature CAD. In particular, we: 1) assessed the...

Full description

Bibliographic Details
Main Authors: Diana N. Vikulova, Ilia S. Skorniakov, Brendon Bitoiu, Chad Brown, Emilie Theberge, Christopher B. Fordyce, Gordon A. Francis, Karin H. Humphries, G.B. John Mancini, Simon N. Pimstone, Liam R. Brunham
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:American Journal of Preventive Cardiology
Subjects:
Premature cardiovascular disease
Clinical practice guidelines
Primary prevention
Eligibility determination
Online Access:http://www.sciencedirect.com/science/article/pii/S2666667720300362

Similar Items

Similar Items